Remove sanofi-and-az-advance-immunization-master-plan-us-nod-infant-rsv-drug-beyfortus
article thumbnail

Sanofi and AZ advance immunization master plan with US nod for infant RSV drug Beyfortus

Fierce Pharma

Sanofi’s immunization scheme is starting to fall into place thanks to an approval that could propel it and its partner AstraZeneca to the front lines of the respiratory syncytial virus (RSV) scene.

241
241